Investor Profile: HealthX Capital - Thesis, Cheque Size & How to Apply

HealthX Capital is a Singapore-based, healthcare-focused early-stage investor backing startups in South East Asia and India. Its pitch to founders is simple: capital that arrives with clinical partners, insurance and medtech contacts, and help commercialising across Asia, not just a cheque. For Indian healthtech founders, that combination matters because selling into hospitals and insurers is slower and more relationship-driven than selling a consumer app.

Thesis

The firm's stated thesis centres on access and affordability. It backs technology that helps healthcare leapfrog existing solutions in emerging Asia, where infrastructure is uneven, treatment costs are high, and data is fragmented. On its official site, HealthX Capital frames its work around three tests: access and affordability, applicability through clinical partners, and commercialisation through insurance, medtech and provider partners. Its interest areas are point-of-care diagnostics and devices, home health solutions, preventive health solutions, digital health solutions, biomarkers and AI and machine learning.

Sectors, stages and fund size

HealthX Capital invests at the early stage, with follow-on support across multiple early rounds. Its maiden fund, announced in 2018, was US$25 million and was expected to back 10 to 12 early-stage startups. Its backers at launch included Apollo Hospitals, Jungle Ventures and Eight Roads Ventures, alongside other undisclosed private investors. Cheque sizes for later vehicles were not stated in the sources read for this profile, so a current standard cheque is recorded here as not publicly disclosed rather than estimated.

Notable portfolio

Early investments named at the launch of the maiden fund were Singapore-based caregiving platform Homage, US-based smartphone diagnostics platform JanaCare, and India-based neonatal analytics provider iNICU. Homage later raised a US$30 million Series C led by Sheares Healthcare Group, with HealthX Capital participating as an existing investor. The firm's site also records a US$2.3 million pre-Series A round for neonatal care company Child Health Imprints, led by HealthX Capital. Later portfolio names tracked by third-party databases include MiyaHealth and RED.Health, the emergency-care platform, though founders should treat database listings as a starting point and verify current holdings before pitching.

Partners, programmes and credits

Partners named on the firm's site include Apollo Hospitals, Jungle Ventures and Eight Roads Ventures, with an advisory board that has included Dr. Arda Minocherhomjee, Dr. Prem Pillay and Dr. Daniel Kraft. The managing partner named in press coverage is Seemant Jauhari. HealthX Capital does not publish a structured accelerator, credits programme or perks catalogue in the sources read for this profile, and no such programme is claimed here. Its stated support is hands-on: clinical validation, market fit work, operational partners, and introductions to follow-on investors.

How to apply for funding

No public application portal was found in the sources read for this profile. Founders should approach HealthX Capital through its official site at healthxcapital.com or through a warm introduction from a clinical, investor or portfolio contact, with a clear note on clinical validation, the care pathway being improved, and evidence that the product works in an Indian or South East Asian care setting.